Loading
Latest filing published 20 Mar 2012 for IDENIX PHARMACEUTICALS INC, €55k.
No signal scores available.
Paul Fanning is a declared insider of Idenix Pharmaceuticals Inc, with filings sourced from SEC (Form 4). In total, 2 filings cover trades dated 16 March 2012.
No open-market purchase appears, only 1 sale worth €253k. The rest of the record consists of 1 option exercise.
On 20 March 2012 came the latest disclosure, an option exercise for €55k in Idenix Pharmaceuticals Inc. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations